N/A
N=279
Supplementing Hearing Aids With Computerized Auditory Training
Hearing Loss
Bottom Line
View on ClinicalTrials.gov: NCT00727337 ↗Enrolled (actual)
279
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcome: Primary: Words-in-Noise Test (WIN) Change — 9.8; 9.9; 9.7; 10.4 dB SNR
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- LACE-computer (Behavioral); PLACEBO-Directed listening (Behavioral); CONTROL (Behavioral); Lace-DVD (Behavioral)
- Age
- Adult, Older Adult · 55+ yrs
- Sex
- All
- Sponsor
- VA Office of Research and Development
- Primary completion
- Apr 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Words-in-Noise Test (WIN) Change |
9.8; 9.9; 9.7; 10.4; 9; 9.2 | — |
| SECONDARY Abbreviated Profile of Hearing Aid Benefit (APHAB) Change |
32.3; 32; 34; 37; 31; 32 | — |
| SECONDARY Hearing Handicap Inventory for the Elderly (HHI) Change |
29.4; 31.3; 29.95; 33.8; 25.65; 29.35 | — |
Summary
The study is designed to examine the effectiveness of a computer-based auditory training program to improve the benefits received by individuals who wear hearing aids. The study will involve 3 groups - a computer-based training group, an active listening group which will involve listening to books on CD, and a placebo group that receives no additional treatment.
Eligibility Criteria
Inclusion Criteria
- adult onset hearing loss,
- English as the first language,
- bilateral, symmetric, sensorineural hearing loss,
- average audiometric thresholds for 500, 1000, and 2000 Hz less than 50-dB HL in either ear,
- aided speech recognition in quiet of 40% binaurally,
- appropriate cognitive skills assessed using the Mini Mental State Exam (Folstein et al., 1975) with age/education norms (Crum et al., 1993),
- adequate vision to participate in the study as determined with the Smith-Kettlewell Institute Low Luminance (SKILL) Card,
- eligible for VA-issued hearing aids.
Exclusion Criteria
known neurological, psychiatric disorders, or co-morbid diseases that would prevent completion of the study as determined by chart review,
Data sourced from ClinicalTrials.gov (NCT00727337). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.